Health Trials

Connective Tissue Disease-associated Interstitial Lung Disease

2

Review clinical trials related to Connective Tissue Disease-associated Interstitial Lung Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA CAR-NK cell injection in patients with refractory pediatric rheumatic diseases.

Participants needed: 36
Trial details
Phase: Early Phase 1Age: 5+Biological sex: AllType: InterventionalSponsor: The Children's Hospital of Zhejiang University School of MedicineUpdated: Mar 24, 2026Locations: 1
Eligibility criteria

. Gender unrestricted, age ≥5 years; [+30]

. History of malignancy (except for basal cell or squamous cell skin cancer or c... [+17]

Read more
Status: Recruiting

A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease

This study evaluates the efficacy and safety of tetrandrine tablets (60 mg, three times daily) compared to placebo in adult patients with connective tissue disease-related interstitial lung disease. Patients receive standard treatment (glucocorticoids and immunosuppressants) alongside the study drug or placebo for 24 weeks. The study measures changes in lung function, inflammatory markers, lung imaging, quality of life, and safety outcomes.

Participants needed: 100
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Peking University Third HospitalUpdated: Jan 6, 2026Locations: 1
Eligibility criteria

Patients who voluntarily participate and sign the informed consent form [+5]

Treatment with tetrandrine or other antifibrotic drugs within 1 month before scr... [+13]

Read more